bpc-157 human clinical trials evidence safety trial fda warning Thinking about trying BPC-157? Read this first. While often marketed as a “healing peptide” BPC-157 is not FDA approved and not pharmacy grade BPC-157 – No Proof Required!

Gastrointestinal symptoms (more common with oral preparations): Mild nausea or upset stomach Diarrhoea (typically with very high doses) Other effects: Headache, particularly when treatment is first initiated Dizziness or light-headedness Skin reactions such as mild rash or itching Temporary reddish discolouration of urine (chromaturia) after hydroxocobalamin injections, which is harmless It is important to note that many symptoms attributed to B12 supplementation may actually represent the body's response to correcting a deficiency

Pain Medication As with any condition causing inflammation and an infection, pain doesnt disappear overnight

Golatta, M., Schweitzer-Martin, M., Harcos, A., Schott, S., Junkermann, H., Rauch, G., et al

That can include medication delivery, transportation, etc

This list may not include all contraindications

human evidence is limited and individual results vary